Healthy volunteers help test Easier-to-Swallow drug form
NCT ID NCT07453784
First seen May 01, 2026 · Last updated May 21, 2026 · Updated 4 times
Summary
This study is testing a new minitablet version of the drug obefazimod in 44 healthy adults aged 18 to 55. The goal is to see how the body processes the minitablet compared to the current capsule and whether the minitablet tastes acceptable. This is an early-stage study that does not treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Quotient Sciences
RECRUITINGNottingham, NG11 6JS, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.